Description |
1 online resource (x, 170 pages) : illustrations |
Series |
Endocrinology research and clinical developments |
|
Metabolic diseases - laboratory and clinical research |
|
Endocrinology research and clinical developments.
|
|
Metabolic diseases--laboratory and clinical research series.
|
Contents |
GROWTH HORMONES: SYNTHESIS, REGULATION AND HEALTH IMPLICATIONS; GROWTH HORMONES: SYNTHESIS, REGULATION AND HEALTH IMPLICATIONS; LIBRARY OF CONGRESS CATALOGING-IN-PUBLICATION DATA; CONTENTS; PREFACE; Chapter 1: BIOTECH PLATFORM FOR DISCOVERY AND ASSESSMENT OF GROWTH HORMONES; 1. MODERN BIOTECHNOLOGY AND THE PRODUCTION OF PROTEIN HORMONES; 2. THE GROWTH HORMONE (GH) FAMILY; 3. GROWTH HORMONES OF ANIMAL ORIGIN; 4. BIOLOGICAL POTENTIAL OF GHS; 5. EXPRESSION SYSTEMS FOR GROWTH HORMONES; 6. TECHNOLOGICAL PLATFORM FOR CLONING GHS; 7. TECHNOLOGICAL PLATFORM FOR PRODUCING RECOMBINANT GHS |
|
8. CONSTRUCTION OF GHS PRODUCING PICHIA PASTORIS STRAINS9. PRODUCTION AND ANALYSIS OF RECOMBINANT HORMONES IN ERLENMEYER FLASK; 10. PRODUCTION SCALING IN THE BIOREACTOR; 11. SEMIPURIFICATION OF RECOMBINANT HORMONES; 12. TESTING THE BIOLOGICAL ACTIVITY OF RECOMBINANT HORMONES; 13. CONTRIBUTIONS; 14. PERSPECTIVES; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: THEORETICAL APPROACHESTO GROWTH HORMONE SIGNALING; Abstract; 1. Introduction; 2. Mathematical Modeling of Ligand-Receptor Systems; 3. 1:1 Interaction Model; 4. 1:2 Symmetric Interaction Model; 5. 1:2 Symmetric and Sequential Interaction Model |
|
6. 1:2 Asymmetric and Sequential Interaction Model7. Self-Antagonist Effect; 8. Enhanced Efficiency of GH Ligand Homodimers; 9. Receptor Monomer Versus Receptor Dimer Hypotheses; 10. Conclusion; 11. Acknowledgments; References; Chapter 3: EFFECT OF GROWTH HORMONE ON LIPID METABOLISM -- BASIC AND CLINICAL ASPECTS; ABSTRACT; ABBREVIATIONS; 1. INTRODUCTION; 2. GROWTH HORMONE: CHEMISTRY, GENE EXPRESSION AND SECRETION CONTROL; 3. GROWTH HORMONE RECEPTOR AND SIGNALING CASCADE; 4. EFFECTS OF GROWTH HORMONE ON LIPID METABOLISM IN THE ADIPOSE TISSUE, LIVER AND SKELETAL MUSCLE |
|
5. STUDIES OF GROWTH HORMONE SECRETION AND ACTIONS IN HUMANS6. OBESITY, METABOLIC SYNDROME AND GROWTH HORMONE; 7. GROWTH HORMONE DEFICIENCY AND VISCERAL (TRUNCAL) OBESITY; 8. GROWTH HORMONE TREATMENT AND PERSPECTIVES; REFERENCES; Chapter 4: THE HUMAN GROWTH HORMONE: SYNTHESIS, REGULATION AND HEALTH IMPLICATIONS; ABSTRACT; I. INTRODUCTION; II. HGH SYNTHESIS AND REGULATION; III. BIOLOGICAL RELEVANCE AND IMPACT ON HEALTH; CONCLUSION; REFERENCES; Chapter 5: CIRCULATION CONCENTRATION OF ESTRADIOL, GROWTH HORMONE, INSULIN LIKE GROWTH FACTOR AFTER FOLLICLE ASPIRATION IN CATTLE; ABSTRACT |
|
1. INTRODUCTION2. MATERIALS AND METHODS; 3. RESULT; 4. DISCUSSION; REFERENCES; Chapter 6: STABILITY STUDY OF SOMATROPIN BY CAPILLARY ZONE ELECTROPHORESIS; ABSTRACT; INTRODUCTION; EXPERIMENTAL; RESULTS AND DISCUSSION; CONCLUSION; REFERENCES; Chapter 7: CARDIAC EFFECTS OF GROWTH HORMONE TREATMENT IN PEDIATRIC POPULATIONS; INTRODUCTION; BACKGROUND; GROWTH HORMONE THERAPY IN THE CARDIAC SETTING; ISOLATED GH DEFICIENCY; TURNER SYNDROME; NOONAN SYNDROME; PRADER-WILLI SYNDROME; SMALL FOR GESTATIONAL AGE (SGA); INDUCED GH DEFICIENCY; CONCLUSION; REFERENCES |
|
Chapter 8: RECOMBINANT HUMAN GROWTH HORMONE TREATMENT IN PATIENTS WITH GROWTH DEFICIENCY AND CROHN'S DISEASE -- NEW PERSPECTIVES |
Bibliography |
Includes bibliographical references and index |
Notes |
"Nova biomedical." |
|
Print version record |
Subject |
Peptide hormones.
|
|
Somatotropin.
|
|
SCIENCE -- Life Sciences -- Developmental Biology.
|
|
Peptide hormones
|
|
Somatotropin
|
Form |
Electronic book
|
Author |
Andersdtr, Anne, editor
|
|
Anderssen, Jon, editor
|
ISBN |
9781619426894 |
|
1619426897 |
|